These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 18163938)

  • 21. [Radiotherapy for high-risk patients after radical prostatectomy for prostate cancer: immediate postoperative or salvage?].
    Pasquier D; Kouto H; Ballereau C
    Prog Urol; 2009 Jul; 19(7):447-56. PubMed ID: 19559374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of salvage therapy for biochemical recurrence on health-related quality of life following radical prostatectomy.
    Namiki S; Saito S; Tochigi T; Ioritani N; Terai A; Arai Y
    Int J Urol; 2007 Mar; 14(3):186-91. PubMed ID: 17430252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [PSA and follow-up after treatment of prostate cancer].
    Benchikh El Fegoun A; Villers A; Moreau JL; Richaud P; Rebillard X; Beuzeboc P
    Prog Urol; 2008 Mar; 18(3):137-44. PubMed ID: 18472065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rising Prostate Specific Antigen following treatment with curative intention].
    Jakobsen H; Pedersen KV
    Ugeskr Laeger; 2007 May; 169(20):1907-9. PubMed ID: 17553369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy.
    Kimura M; Mouraviev V; Tsivian M; Mayes JM; Satoh T; Polascik TJ
    BJU Int; 2010 Jan; 105(2):191-201. PubMed ID: 19583717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
    Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
    BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
    Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
    Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of prostate cancer recurrence after definitive radiation therapy.
    Boukaram C; Hannoun-Levi JM
    Cancer Treat Rev; 2010 Apr; 36(2):91-100. PubMed ID: 20100637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage radical prostatectomy: refinement of an effective procedure.
    Pisters LL
    Semin Radiat Oncol; 2003 Apr; 13(2):166-74. PubMed ID: 12728446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rising prostate-specific antigen after primary prostate cancer therapy.
    Ward JF; Moul JW
    Nat Clin Pract Urol; 2005 Apr; 2(4):174-82. PubMed ID: 16474760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy.
    Pearce A; Choo R; Danjoux C; Morton G; Loblaw DA; Szumacher E; Cheung P; Deboer G; Chander S
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):78-83. PubMed ID: 16563657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients.
    Ismail M; Ahmed S; Kastner C; Davies J
    BJU Int; 2007 Oct; 100(4):760-4. PubMed ID: 17662081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of local salvage therapies following radiation failure for prostate cancer.
    Touma NJ; Izawa JI; Chin JL
    J Urol; 2005 Feb; 173(2):373-9. PubMed ID: 15643174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Salvage radiotherapy for pT3 prostate cancer with PSA failure after radical prostatectomy].
    Wakita T; Hayashi N; Fuwa N
    Hinyokika Kiyo; 2005 Sep; 51(9):575-80. PubMed ID: 16229369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rising prostate-specific antigen after primary treatment of prostate cancer: sequential hormone manipulation.
    Schmid HP; Keuler FU; Altwein JE
    Urol Int; 2007; 79(2):95-104. PubMed ID: 17851276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
    Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
    Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Salvage external beam radiotherapy for prostate cancer biochemical recurrence after radical prostatectomy].
    Martín FL; García PD
    Arch Esp Urol; 2012; 65(1):131-44. PubMed ID: 22318184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parameters for treatment decisions for salvage radiation therapy.
    Hayes SB; Pollack A
    J Clin Oncol; 2005 Nov; 23(32):8204-11. PubMed ID: 16278474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Salvage brachytherapy for prostate cancer biochemical recurrence after radiotherapy].
    Rubio AP; López IJ
    Arch Esp Urol; 2012; 65(1):145-57. PubMed ID: 22318185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: comparisons among ASTRO and Phoenix biochemical failure definitions].
    Quero L; Mongiat-Artus P; Ravery V; Hennequin V; Maylin C; Desgrandchamps F; Hennequin C
    Cancer Radiother; 2009 Jul; 13(4):267-75. PubMed ID: 19446487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.